H. Pylori Eradication for Moderate ITP

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to determine the efficacy of H. pylori eradication for the treatment of chronic or persistent immune thrombocytopenic purpura (ITP) patients with moderate thrombocytopenia. This is a multi-center, open label, prospective randomized phase IIl study.
Epistemonikos ID: 3dd5171fd663f7b00a75e30305d262613efbeca2
First added on: May 20, 2024